✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Repligen Corp

Common Name
Repligen
Country
United States
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
1,778
Ticker
RGEN
Exchange
NASDAQ/NGS
Description
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems to support the manufacturing of biologic drugs, including monoclonal anti...

Repligen's Revenues Data

Explore Repligen's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
738,256,000a
634,439,000a
632,362,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Repligen’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Repligen's 10-K 2025